NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

SARS-CoV-2 Infection and COVID-19 During Pregnancy: A

Evaluation & Management of COVID-19 in Pregnancy

NIH Coronavirus Funding

Remdesivir: A beacon of hope from Ebola virus disease to COVID‐19

Remdesivir COVID-19 Treatment Guidelines

COVID-19 Treatments: What We Know So Far > News > Yale Medicine

Coronavirus Drug and Treatment Tracker - The New York Times

Infectious Disease Reports, Free Full-Text

Management Strategies in Children and Adolescents with Mild to